Oncospace Inc.

UEI
HSG5CY5VWW33
CAGE
86PW3
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
sunnuclear.com
Founded
1984
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $111,800
FY2023 $399,870

Contract awards

Grant awards

Similar vendors

About the company

Oncospace Inc. is a Baltimore-based corporate entity specializing in artificial intelligence and data analytics solutions for radiation therapy and healthcare optimization. Registered in SAM.gov since April 2019, the company focuses on developing advanced software tools that enhance treatment planning, quality assurance, and patient outcome prediction in oncology. Founded in 2018, Oncospace has a unique team that includes creators of significant radiation therapy technologies like the Pinnacle Radiation Therapy Planning System and Tomotherapy Radiation Treatment Delivery System.

Through federal contract awards, Oncospace Inc. has secured multiple small business set-aside contracts, primarily in the healthcare and data services sectors. The company was awarded a $111,800 firm fixed-price purchase order from the Department of Veterans Affairs for data backup services, with a completion date of January 29, 2026. Additionally, the firm received a $399,870 Small Business Innovation Research (SBIR) Phase I contract from the National Cancer Institute to develop a software tool for standardizing radiotherapy treatment plans to support artificial intelligence validation. These contracts demonstrate the company's expertise in developing sophisticated data analytics and software solutions for medical applications.

In the federal grant arena, Oncospace Inc. has received significant awards from prominent research agencies. The National Cancer Institute awarded them a grant (R43CA254559) to develop a system for xerostomia risk classification after head and neck cancer radiotherapy, focusing on creating a predictive model using over 1,200 patient records. Another substantial grant from the National Science Foundation (Award 2035750) supported an SBIR Phase II project for developing a cloud-native, data-driven platform for automated quality assurance of radiation oncology treatment planning. These grants, totaling significant funding, underscore the company's commitment to innovative healthcare technology and its ability to secure competitive research funding for advanced medical software development.

Quick answers

Is Oncospace Inc. registered in SAM.gov?

Oncospace Inc.'s SAM.gov registration expired on April 18, 2026.

What is Oncospace Inc.'s CAGE code?

Oncospace Inc.'s CAGE code is 86PW3, and its Unique Entity ID (UEI) is HSG5CY5VWW33.

How much has Oncospace Inc. received in federal contracts?

Federal contracts obligated $511,670 to Oncospace Inc. in fiscal years 2023 through 2027.

What is Oncospace Inc.'s most recent federal award?

Oncospace Inc.'s most recent federal contract award is Data backup (36C24524P0786), from Veterans Integrated Service Network 5 (VHA), on September 30, 2024.

On GovTribe

See Oncospace Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe